{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04057898",
            "orgStudyIdInfo": {
                "id": "MN-166-ALS-2301"
            },
            "organization": {
                "fullName": "MediciNova",
                "class": "INDUSTRY"
            },
            "briefTitle": "Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS",
            "officialTitle": "A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis",
            "acronym": "COMBAT-ALS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "evaluation-of-mn-ibudilast-for-months-followed-by-an-open-label-extension-for-months-in-patients-with-als"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-05-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-08-06",
            "studyFirstSubmitQcDate": "2019-08-13",
            "studyFirstPostDateStruct": {
                "date": "2019-08-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "MediciNova",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of MN-166 given to ALS participants for 12 months followed by a 6-month open-label extension phase.",
            "detailedDescription": "This is a Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of MN-166 followed by an open-label extension phase compared to matching placebo in subjects diagnosed with ALS.\n\nThe study will consist of a screening phase (up to 30 days) followed by a double-blind phase (12 months). Following the screening phase, subjects who continue to meet entry criteria will be randomly assigned to one of two treatment groups: MN-166 or matching placebo in a 1:1 ratio. Upon completion of the double-blind phase, subjects will be given the option to continue to the Open-label Extension Phase for a period of six months."
        },
        "conditionsModule": {
            "conditions": [
                "Amyotrophic Lateral Sclerosis"
            ],
            "keywords": [
                "ALS",
                "MN-166",
                "ibudilast",
                "amyotrophic lateral sclerosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 230,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "MN-166",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects will take MN-166 10 mg capsules, up to 50 mg twice a day for 12 months.",
                    "interventionNames": [
                        "Drug: MN-166"
                    ]
                },
                {
                    "label": "placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Subjects will take up to 5 matching placebo capsules twice a day for 12 months.",
                    "interventionNames": [
                        "Drug: placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "MN-166",
                    "description": "Subjects will take MN-166 for 12 months followed by a 6-month open-label extension phase.",
                    "armGroupLabels": [
                        "MN-166"
                    ],
                    "otherNames": [
                        "ibudilast"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "placebo",
                    "description": "Subjects will take matching placebo for 12 months followed by a 6-month open-label extension phase.",
                    "armGroupLabels": [
                        "placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change from baseline in ALSFRS-R score at Month 12 (or last measurement before death in case of censoring) and survival time.",
                    "description": "The amyotrophic lateral sclerosis functional rating scale-revised, or ALSFRS-R, measures the functional status of subjects with ALS. It is based on 12 items, each of which is rated on a 5-point scale (0 to 4). The rate of total functional disability thus ranges from 0 (maximum disability) to 48 (normal function) points.",
                    "timeFrame": "12 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean change from baseline of muscle strength measured by hand-held dynamometry",
                    "description": "Hand-held dynamometry, or HHD, is used to measure the force generated by each muscle. The scale ranges from 0 (no visible movement of the part) to 10 (holds test position against strong pressure). Thus, the higher the total score, the higher muscle strength is observed.",
                    "timeFrame": "Baseline, Treatment Phase Week 6, Months 3, 6, 9 and12 time points."
                },
                {
                    "measure": "Mean change from baseline on quality of life assessed by ALSAQ-5 at Month 12",
                    "description": "The Amyotrophic Lateral Sclerosis Assessment Questionnaire, or ALSAQ-5, is a patient self-report questionnaire specifically designed to measure 5 areas of health: physical mobility, activities of daily living and independence, eating and drinking, communication and emotional functioning. The subject is asked about 5 different areas of difficulties in their daily lives: ability to stand up, use of limbs, consuming solid food, level of speech coherence, and degree of hope about the future.Each question provides 5 choices from which to choose: Never, Rarely, Sometimes, Often, and Always or cannot do at all.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Mean change from baseline of functional activity measured by ALSFRS-R at Month 12",
                    "description": "The ALSFRS-R assessment tool measures the functional status of subjects with ALS. It is based on 12 items, each of which is rated on a 5-point scale (0 to 4). The rate of total functional disability thus ranges from 0 (maximum disability) to 48 (normal function) points. In this context, the ALSFRS-R total score change (lower, same, higher) is documented.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Responders, measured in percent of subjects overall, whose ALSFRS-R total score was stable or improved",
                    "description": "Proportion of subjects in which ALSFRS-R total score was stable or improved.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Time to survival",
                    "description": "Defined by death or permanent dependency to ventilator or tracheostomy.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0",
                    "description": "The incidence of treatment-emergent adverse events (TEAEs), severity (mild, moderate, severe), as well as relationship to study treatment (not related, possibly related, probably related) and whether they are considered serious.",
                    "timeFrame": "12 months"
                },
                {
                    "measure": "Changes from Baseline in Laboratory Values",
                    "description": "Incidence of out-of-normal-range values and markedly abnormal change from baseline in laboratory safety test variables by treatment group.",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Major Inclusion Criteria:\n\n* Male or female subjects age 18 - 80 years, inclusive;\n* Diagnosis of familial or sporadic ALS as defined by the El Escorial-Revised (2000) research diagnostic criteria for ALS \\[clinically definite, clinically probable, probable-laboratory-supported\\];\n* ALS onset of \u226418 months from first clinical signs of weakness prior to screening;\n* If currently using riluzole, subject must be on a stable dose for at least 30 days prior to initiation of study drug;\n* If currently using edaravone, subject should have completed at least 14 days of their initial treatment cycle prior to initiation of study drug;\n* Last documented pulmonary function test result (i.e., slow vital capacity or forced vital capacity) must be greater than or equal to 70% predicted;\n* Able to swallow study medication capsules;\n* No known allergies to the study drug or its excipients;\n* Received pneumococcal vaccine within 6 years prior to starting clinical trial.\n\nMajor Exclusion Criteria:\n\n* Confirmed hepatic insufficiency or abnormal liver function (AST and/or ALT \\>3 times upper limit of normal);\n* Currently diagnosed with a clinically significant psychiatric disorder or dementia that would preclude evaluation of symptoms;\n* Currently use or treated with parenteral (intramuscular or intravenous) high dose (\\>25 mg/week) Vitamin B12 within 30 days prior to study drug administration;\n* Poor peripheral venous access that will limit the ability to draw blood as judged by the Investigator;\n* Currently participating, or has participated in a study with an investigational or marketed compound or device within 30 days or 5 half-lives, whichever is shorter, prior to signing the informed consent;\n* Use of tracheostomy or \\>22/24-hour ventilatory support.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "80 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Project Management Team",
                    "role": "CONTACT",
                    "phone": "858-373-1500",
                    "email": "clinicaltrialinfo@medicinova.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Project Management Team",
                    "affiliation": "Medicinova Inc",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "California",
                    "zip": "92868",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Namita Goyal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.78779,
                        "lon": -117.85311
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bjorn Oskarsson, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Augusta University",
                    "status": "RECRUITING",
                    "city": "Augusta",
                    "state": "Georgia",
                    "zip": "30912",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Rivner, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.47097,
                        "lon": -81.97484
                    }
                },
                {
                    "facility": "Indiana University IU Health Neuroscience Center",
                    "status": "RECRUITING",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cynthia Bodkin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Johns Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nicholas Maragakis, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Hennepin Healthcare Research Institute",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55415",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Samuel Maiser, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "SUNY Upstate Medical University",
                    "status": "RECRUITING",
                    "city": "Syracuse",
                    "state": "New York",
                    "zip": "13210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jenny Meyer, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.04812,
                        "lon": -76.14742
                    }
                },
                {
                    "facility": "Duke University",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27705",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Richard Bedlack, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Lehigh Valley Health Network",
                    "status": "RECRUITING",
                    "city": "Allentown",
                    "state": "Pennsylvania",
                    "zip": "18103",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alison Walsh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.60843,
                        "lon": -75.49018
                    }
                },
                {
                    "facility": "University of Virginia Health System",
                    "status": "RECRUITING",
                    "city": "Charlottesville",
                    "state": "Virginia",
                    "zip": "22908",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Elliott, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.02931,
                        "lon": -78.47668
                    }
                },
                {
                    "facility": "University of Alberta Hospital",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 2G3",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Wendy Johnston, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "McMaster University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "Ontario",
                    "zip": "L8N 3Z5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "John Turnbull, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.25011,
                        "lon": -79.84963
                    }
                },
                {
                    "facility": "Sunnybrook Research Institute",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M4N 3M5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Lorne Zinman, MD MSc",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Montreal Neurological Institute and Hospital",
                    "status": "RECRUITING",
                    "city": "Montreal",
                    "state": "Quebec",
                    "zip": "H3A 2B4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Angela Genge, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Clinique Maladies Neuromusculaire",
                    "status": "RECRUITING",
                    "city": "Sherbrooke",
                    "state": "Quebec",
                    "zip": "J1H 5N4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Sylvie Gosselin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.40008,
                        "lon": -71.89908
                    }
                },
                {
                    "facility": "University of Saskatchewan - Sastakoon Hospital",
                    "status": "RECRUITING",
                    "city": "Saskatoon",
                    "state": "Saskatchwean",
                    "zip": "S7K 0M7",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Kerri Schellenberg, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.13238,
                        "lon": -106.66892
                    }
                },
                {
                    "facility": "Hopital de L'Enfant-Jesus, CHU de Quebec-Universite Laval",
                    "status": "RECRUITING",
                    "city": "Quebec",
                    "zip": "G1J 1Z4",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Annie Dionne, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.81228,
                        "lon": -71.21454
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "34816762",
                    "type": "BACKGROUND",
                    "citation": "Oskarsson B, Maragakis N, Bedlack RS, Goyal N, Meyer JA, Genge A, Bodkin C, Maiser S, Staff N, Zinman L, Olney N, Turnbull J, Brooks BR, Klonowski E, Makhay M, Yasui S, Matsuda K. MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design. Neurodegener Dis Manag. 2021 Dec;11(6):431-443. doi: 10.2217/nmt-2021-0042. Epub 2021 Nov 24."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "This webinar explains the COMBAT-ALS study design and background of MN-166 (ibudilast) as a potential treatment for ALS.",
                    "url": "https://medicinova.com/medicinova-webinar/"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016472",
                    "term": "Motor Neuron Disease"
                },
                {
                    "id": "D000000690",
                    "term": "Amyotrophic Lateral Sclerosis"
                },
                {
                    "id": "D000012598",
                    "term": "Sclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000013118",
                    "term": "Spinal Cord Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000057177",
                    "term": "TDP-43 Proteinopathies"
                },
                {
                    "id": "D000057165",
                    "term": "Proteostasis Deficiencies"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18879",
                    "name": "Motor Neuron Disease",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4024",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15415",
                    "name": "Sclerosis",
                    "asFound": "Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15915",
                    "name": "Spinal Cord Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28759",
                    "name": "TDP-43 Proteinopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M28747",
                    "name": "Proteostasis Deficiencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T349",
                    "name": "Amyotrophic Lateral Sclerosis",
                    "asFound": "Amyotrophic Lateral Sclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4699",
                    "name": "Primary Lateral Sclerosis",
                    "asFound": "Lateral Sclerosis",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000038366",
                    "term": "Ibudilast"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001993",
                    "term": "Bronchodilator Agents"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000010726",
                    "term": "Phosphodiesterase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000010975",
                    "term": "Platelet Aggregation Inhibitors"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M242770",
                    "name": "Ibudilast",
                    "asFound": "Trometamol",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5269",
                    "name": "Bronchodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M13629",
                    "name": "Phosphodiesterase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M13865",
                    "name": "Platelet Aggregation Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "PlAggInh",
                    "name": "Platelet Aggregation Inhibitors"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}